Patents by Inventor Tracey Dugan

Tracey Dugan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Decorin proteoglycan inhibitor of fibrinogen blood clotting
    Publication number: 20060258570
    Abstract: The present invention provides compositions and methods of inhibiting fibrin(ogen) clot formation by utilizing decorin proteoglycan as an anticoagulating and antithrombotic agent. The decorin proteoglycan comprises a decorin core protein or a fragment thereof covalently linked to a galactosaminoglycan polysaccharide. The decorin core protein acts as an anticoagulant and as a carrier for the delivery of an antithrombotic galactosaminoglycan to fibrinogen. Fibrin clotting is inhibited by the decorin proteoglycan in a concentration-dependent fashion.
    Type: Application
    Filed: July 24, 2006
    Publication date: November 16, 2006
    Inventors: Magnus Hook, Tracey Dugan
  • Decorin proteoglycan inhibitor of fibrinogen blood clotting
    Patent number: 7094880
    Abstract: The present invention provides compositions and methods of inhibiting fibrin(ogen) clot formation by utilizing decorin proteoglycan as an anticoagulating and antithrombotic agent. The decorin proteoglycan comprises a decorin core protein or a fragment thereof covalently linked to a galactosaminoglycan polysaccharide. The decorin core protein acts as an anticoagulant and as a carrier for the delivery of an antithrombotic galactosaminoglycan to fibrinogen. Fibrin clotting is inhibited by the decorin proteoglycan in a concentration-dependent fashion.
    Type: Grant
    Filed: July 26, 2004
    Date of Patent: August 22, 2006
    Assignee: The Texas A&M University System
    Inventors: Magnus Höök, Tracey A. Dugan
  • Decorin proteoglycan inhibitor of fibrinogen blood clotting
    Publication number: 20050020491
    Abstract: The present invention provides compositions and methods of inhibiting fibrin(ogen) clot formation by utilizing decorin proteoglycan as an anticoagulating and antithrombotic agent. The decorin proteoglycan comprises a decorin core protein or a fragment thereof covalently linked to a galactosaminoglycan polysaccharide. The decorin core protein acts as an anticoagulant and as a carrier for the delivery of an antithrombotic galactosaminoglycan to fibrinogen. Fibrin clotting is inhibited by the decorin proteoglycan in a concentration-dependent fashion.
    Type: Application
    Filed: July 26, 2004
    Publication date: January 27, 2005
    Inventors: Magnus Hook, Tracey Dugan